OP0251 Attainment of low disease activity and remission in systemic lupus erythematosus patients with high disease activity in the atacicept phase iib address ii study and its long-term extension
Morand, E., Merrill, J.T., Isenberg, D.A., Kao, A.H., Vazquez–Mateo, C., Wax, S., Chang, P., Pudota, K., Aranow, C., Wallace, D.
Published in Annals of the rheumatic diseases (01.06.2018)
Published in Annals of the rheumatic diseases (01.06.2018)
Get full text
Journal Article